Benelux
Phoenix Court Group raises USD 500m for four VC strategies
London-headquartered VC is raising for its LocalGlobe, Latitude, Solar and Basecamp funds
Kester nets 8x on Avania exit to Astorg
Medical device CRO is Astorg's first healthcare deal from its EUR 1.3bn Mid-Cap fund
GP Profile: Ergon hones in on long-term trends, ESG agenda
The European mid-market sponsor is eyeing growing and resilient businesses with its EUR 800m Fund V
LGT Capital closes first dedicated impact fund on USD 550m
Crown Impact will make co-investments, as well as primary and secondary fund investments
IK pauses Ampelmann auction amid macro concerns
Buyer interest dampened by Dutch offshore access systems developer's exposure to Russia
Gimv launches life sciences investment platform
Sponsor seeks to double portfolio and invest bigger tickets in drug development companies
Multiples Heatmap: PE activity holds up amid war, inflation woes
Record levels of dry powder continue to bolster the resilience of the buyout market in Q1 2022
Main Capital on the road for debut growth fund with more fundraises in sight
New vintage of existing strategies and a healthcare-focused continuation fund are also on the agenda for the software-focused GP, according to founding partner and CEO Charly Zwemstra
Synergia plans EUR 200m Fund VI final close by end of 2022
GP is targeting family offices and entrepreneurs and aims to hold a EUR 150m first close by the end of June
Unigestion launches third Direct fund with EUR 1bn target
Strategy invests in mid-market companies alongside the GP's investment partner network
Forbion exceeds Growth Opportunities II target with EUR 470m first close
Biopharma GP sees growing demand for private capital amid IPO lull; gears up for EUR 600m hard-cap by summer end
LPs' net returns highest since financial crisis – Coller Capital
Secondaries specialist’s Summer 2022 Barometer shows that half of LPs want to increase their allocation to alternatives, with 91% still committing to PE first closes with incentives
Advent and Lanxess form EUR 3.7bn polymers JV with Royal DSM carve-out
Buyers pay EUR 3.7bn for DEM; the new unit has sales of over EUR 3bn and EBITDA of EUR 500m
Bain acquires majority stake in Naxicap-backed House of HR
Naxicap will continue its 10-year ownership period, retaining a minority stake in the HR services group
Goldman Sachs AM beats sponsors to buy Norgine
Buyer's PE arm competed with Bain and Cinven in the auction second round
IK to sell 2Connect in SBO to Rivean
Management of the Dutch cable and connectors manufacturer will reinvest in the transaction
EMZ in final stretch of EUR 1.2bn EMZ 10 fundraise
EMZ 10 held a first close in excess of EUR 800m earlier in May and continues to seek new LPs
Argos Wityu appoints head of ESG
Jessica Peters joins the sponsor’s Brussels office to further integrate ESG into the GP and its portfolio companies
Equistone files seventh buyout fund
Equistone VI was 61% deployed as of December 2021 and has made 26 investments to date against the 25-30 deals it can make
Tikehau, Unilever, Axa form EUR 1bn impact fund
Each party has made a EUR 100m commitment and the agriculture-focused fund is now open to new LPs
Schroders gears up for new VC fund-of-funds
Schroders Capital Private Equity Global Innovation Management XI has been registered in Luxembourg
Ergon holds EUR 800m final close for Fund V
New EUR 800m fund is almost 40% larger than its EUR 580m, 2018-vintage predecessor
QPE backs MBO of Republic M!
The buyout of the British commercial services outsourcer is QPE's seventh platform deal under its maiden fund
Naxicap preps for Fund III with eyes set on DACH, Benelux expansion
Sponsor expected to hit the road “soon” for its new EUR 1bn-plus small mid-cap buyout fund
